| Patent application number | Description | Published |
|---|
| 20080214561 | SOLID FORMS OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-1-YL-[5-METHANESULFONYL-2-((S)-2,2,2-TRIFLUORO-1-METHYL-ETHOXY)-PHENYL]-METHANONE - The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions. The compounds of present invention are suitable for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease. | 09-04-2008 |
| 20080221166 | AMINOAMIDES AS OREXIN ANTAGONISTS - The present invention relates to compounds of formula I | 09-11-2008 |
| 20080249125 | HETEROCYCLIC DERIVATIVES AS OREXIN ANTAGONISTS - The present invention relates to compounds of formula | 10-09-2008 |
| 20080249180 | MALONAMIDES AS OREXIN ANTAGONISTS - The present invention relates to compounds of formula I | 10-09-2008 |
| 20080287455 | SULFANYL SUBSTITUTED PHENYL METHANONES - The present invention relates to compounds of formula I | 11-20-2008 |
| 20090036422 | MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - The present invention relates to compounds of formula | 02-05-2009 |
| 20090163485 | HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - The present invention relates to compounds of formula | 06-25-2009 |
| 20090186920 | SULFONAMIDES AS OREXIN ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula | 07-23-2009 |
| 20090192136 | BENZOYL-PIPERAZINE DERIVATIVES - A compound of formula | 07-30-2009 |
| 20090203665 | HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES - The present invention relates to compounds of formula I | 08-13-2009 |
| 20090203736 | PIPERIDINE SULPHONAMIDE DERIVATIVES - The present invention relates to piperidine sulphonamide derivatives of formula | 08-13-2009 |
| 20090312314 | HETEROAROMATIC MONOAMIDES AS OREXININ RECEPTOR ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula | 12-17-2009 |
| 20100029664 | PYRROLIDIN-3-YLMETHYL-AMINE AS OREXIN ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula I | 02-04-2010 |
| 20100048531 | GlyT1 RECEPTOR ANTAGONISTS - The present invention relates to a compound of formula I | 02-25-2010 |
| 20100111862 | RADIOLABELLED INHIBITORS OF THE GLYCINE 1 TRANSPORTER - The present invention relates to novel radiolabelled inhibitors of formula I for the Glycine 1 transporter (GlyT1), useful for the labelling and diagnostic imaging of the glycine 1 transporter functionality. | 05-06-2010 |
| 20100120751 | SPIRO-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENES - The present invention is concerned with spiro-dihydrotetraazabenzoazulenes, i.e. spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes of formula I | 05-13-2010 |
| 20100197715 | PIPERIDINE DERIVATIVES - The present invention relates to a compound of formula I | 08-05-2010 |
| 20100210592 | AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS - The invention relates to the use of compounds of formula I | 08-19-2010 |
| 20100311971 | SOLID FORMS OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-1-YL-[5-METHANESUL- FONYL-2-((S)-2,2,2-TRIFLUORO-1-METHYL-ETHOXY)-PHENYL]-METHANONE - The present invention relates to four distinct crystalline forms and to an amorphous form of [4-(3-Fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone, and to their use in the preparation of pharmaceutical compositions. The compounds of present invention are suitable for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease. | 12-09-2010 |
| 20110053904 | CARBOCYCLIC GLYT1 RECEPTOR ANTAGONISTS - The present invention relates to the use of a compound of formula I | 03-03-2011 |
| 20110071154 | PYRROLIDIN-3-YLMETHYL-AMINE AS OREXIN ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula I | 03-24-2011 |
| 20110144097 | 2-AMINO-5,5-DIFLUORO-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-PHENYL]-AMIDES - The present invention relates to 2-Amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides of formula I | 06-16-2011 |
